Letzo

TYPE: Prescription

BRAND: Letzo

ACTIVE INGREDIENT: Letrozole

STRENGTH & PACK SIZE & GMS CODES:

2.5 mg Film-Coated Tablets x 30 ~ 24525 


INDICATION:

Adjuvant treatment of postmenopausal women with hormone receptor positive invasive early breastcancer.

Extended adjuvant treatment of hormone-dependent invasive breast cancer in postmenopausal women who 
have received prior standard adjuvant tamoxifen therapy for 5 years.

First-line treatment in postmenopausal women with hormone-dependent advanced breast cancer. Advanced 
breast cancer after relapse or disease progression, in women with natural or artificially induced postmenopausal
endocrine status, who have previously been treated with anti-oestrogens.

Neo-adjuvant treatment of postmenopausal women with hormone receptor positive, HER-2 negative breast 
cancer where chemotherapy is not suitable and immediate surgery not indicated.

Efficacy has not been demonstrated in patients with hormone receptor negative breast cancer.



 

Download Letzo 2.5mg SPC here


Download Letzo 2.5mg PIL here




Back to Specialised Products page
Sitemap